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Pregnancy associated osteoporosis 
– a case report
Osteoporoza związana z ciążą – opis przypadku
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Katedra i Zakład Medycyny Rodzinnej, 
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Polska
 Abstract
Loss of bone mineral density (BMD) – usually temporary – occurs during pregnancy and lactation. Pregnancy 
associated osteoporosis (PAO) is an uncommon disease of unknown etiology. We present a case of a 35-year old 
woman with PAO, manifesting initially at the end of the first pregnancy as back pain. It reappeared in the second 
pregnancy, four years later. X-ray revealed multilevel compression fractures of Th12, L1, L2. DEXA showed L2-L4 
T-score: -3.3 SD, hip T-score: -2.09 SD. Laboratory findings were irrelevant. She was put on antiresorptive treatment, 
calcium and vitamin D. Although there has been an improvement in BMD, the patient is a definite candidate for 
vertebral kyphoplasty due to disabling pain.
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 Streszczenie
W czasie ciąży i laktacji dochodzi do utraty gęstości masy kostnej, jednak najczęściej jest ona przejściowa. Os-
teoporoza związana z ciążą (pregnancy associated osteoporosis – PAO) jest rzadką chorobą o nieznanej etiologii. 
Prezentujemy przypadek 35-letniej kobiety, u której choroba manifestowała się początkowo pod koniec pierwszej 
ciąży bólem pleców. Pojawiły się one także w drugiej ciąży, cztery lata później. Rtg ujawniło wielopoziomowe złama-
nia kompresyjne Th12, L1, L2. Densytometria wykazała T- score L2-L4: -3,3 SD, T-score z bliższego końca kości 
udowej: -2,09 SD. Wyniki badań laboratoryjnych nie wykazały istotnych patologii. Chora została poddana leczeniu 
przeciwresorpcyjnemu, preparatami wapnia i witaminy D. Mimo, że nastąpiła poprawa w zakresie parametrów 
densytometrycznych, ból w dalszym ciągu znacznie upośledza życie pacjentki i powoduje, że jest ona kandydatką 
do vertebroplastyki.
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Introduction 
Osteoporosis	 is	 a	disease	of	 an	old	 age,	most	prevalent	 in	
postmenopausal	 women.	 Pregnancy	 associated	 osteoporosis	
(PAO)	 is	 a	 rare	 condition	 of	 unknown	 etiology.	 Since	 the	 first	
report	 in	 1948,	 about	 100	 cases	 have	 been	 described	 [1].	 It	
manifests	generally	in	primiparas	at	the	end	of	pregnancy	or	in	
the	 postpartum	 period	 and	 presents	with	 rapid	 onset	 of	 severe	
back	pain.	It	is	often	a	result	of	multiple	vertebral	fractures,	that	
may	be	an	indication	for	surgery	in	the	postpartum	period.	Rarity	
of	the	disease	often	causes	a	significant	delay	in	diagnosis.	Thus,	
patients	might	not	be	treated	accurately	and	may	suffer	from	life-
threatening	complications.	In	this	paper	we	present	a	case	of	a	35-
year	old	woman	with	a	 long	history	of	osteoporosis	diagnosed	
during	the	second	pregnancy.
Case presentation
A	 35-year-old	 Caucasian	 female	 was	 consulted	 at	 the	
Endocrinology	Outpatient	Clinic,	University	Hospital	No.	 2	 in	
Poznan,	Poland,	due	to	growing	intensity	of	back	pain.	Complaints	
began	in	the	last	trimester	of	the	first	pregnancy	(the	patient	was	
then	22	years	old)	and	were	classified	as	non-specific	low	back	
pain,	with	no	further	diagnostics.	The	patient	was	breastfeeding	
for	the	next	three	months.	In	2001,	at	the	end	of	the	third	trimester	
of	her	second	pregnancy,	girdle	pain	in	the	thoracic	and	lumbar	
spine	 substantially	 intensified.	 Neurological	 examination	 was	
unremarkable	 with	 no	 focal	 signs.	 The	 pregnancy	 ended	 in	
cesarean	section	(healthy	male,	birthweight	3250	g).	The	woman	
was	 hospitalized	 at	 the	 Department	 of	 Neurology.	 The	 X-ray	
showed	 multilevel	 fractures	 of	 Th12,	 L1,	 L2.	 Osteoporosis	
complicated	by	compression	vertebral	fractures	was	diagnosed.	
Laboratory	 tests	 revealed	 serum	 levels	 of	 calcium,	 alkaline	
phosphatase	and	parathyroid	hormone	 to	be	normal,	phosphate	
excretion	in	the	urine	was	slightly	reduced.	
In	 2001,	 patient’s	 height	 was	 162	 cm	 (2-cm	 defect	 in	
comparison	to	the	pre-pregnancy	height).	Subsequently,	she	was	
discouraged	 from	 lactation,	 provided	with	 the	 Javette’s	 corset,	
treated	with	salmon	calcitonin	nasal,	alfacalcidol	and	NSAIDs,	
which	 relieved	 the	 pain.	 Diagnostic	 test	 for	 malabsorption	
syndrome	was	also	undertaken	but	it	was	negative.	DEXA	(dual	
X-ray	absorptiometr)	 (Lunar	DPX-L,	Lunar	Inc.,	Madison,	Wi,	
USA)	showed	the	following	parameters	of	bone	mineral	density	
(BMD):
–		L2-L4	 BMD:	 0.804g/cm²,	 T-score:	 -3.3	 SD,	 Z-score:	
-3.17	SD
–		hip	BMD:	0.729g/cm²,	T-score:	-2.09	SD,	Z-score:	-2.06	
SD
–		distal	 forearm	 BMD:	 0.250g/cm²,	 T-score:	 -3.48	 SD,	
Z-score:	-3.48	SD.
MRI	 of	 the	 spine	 performed	 3	 months	 after	 the	 delivery	
confirmed	compression	fracture	of	Th8	and	L1	and	infraction	of	
upper	epiphyseal	plate	of	10th,	11th	and	12th	 thoracic	vertebrae.	
Neither	 neoplastic	 invasion	 nor	 compression	 of	 the	 spinal	
cord	 were	 found.	 The	 patient	 was	 recommended	 therapy	 with	
antifracture	 medications	 accompanied	 by	 supplementation	
of	 calcium	 and	 vitamin	 D,	 which	 were	 continued	 in	 the	 next	
years	(salmon	calcitonin	nasal,	alendronate	sodium,	risedronate	
sodium).	
The	patient,	gravida	2,	para	2,	no	miscarriages,	had	her	first	
menarche	and	has	been	menstruating	regularly.	
During	the	pregnancies	there	was	no	calcium	supplementation.	
Before	the	diagnosis	of	osteoporosis	the	patient	had	not	suffered	
from	any	serious	diseases,	and	had	not	been	diagnosed	with	any	
chronic	 diseases.	 She	 also	 had	 not	 taken	 any	 drugs	 that	might	
have	affected	bone	metabolism,	including	hormonal	drugs.	Her	
calcium	intake	was	estimated	at	600mg	per	day.	There	were	no	
low-energy	fractures	in	her	family	history.	For	three	years	before	
the	first	pregnancy	the	patient	smoked	5	cigarettes/day	
Physical	 examination	 in	 2011	 revealed	 –	 height	 161	 cm,	
weight	62	kg;	pain	on	palpation	and	limitation	of	movement	of	
thoracic	and	lumbar	spine,	painful	tension	of	paraspinal	muscles.	
No	 abnormalities	 were	 found	 on	 neurological	 examination.	
Medication	 taken	 a	 the	 time	 were:	 risedronate	 35	 mg/week,	
alfacalcidol	1	mg/day,	calcium	carbonate	400mg/day.	Periodically,	
the	 pain	 has	 been	 intensifying	 and	 remarkably	 limiting	 the	
mobility	of	the	patient.	Since	the	diagnosis	she	has	been	receiving	
a	disability	pension.	Attempts	to	take	up	even	part-time	job	failed	
due	to	pain,	increasing	over	the	last	three	months	preceeding	the	
visit.	Spine	X-rays	confirmed	previous	findings	and	revealed	no	
new	ones.	Because	back	pain	was	poorly	responsive	to	treatment,	
the	patient	was	 referred	 to	MRI,	 (Figure	1),	which	showed	 the	
deepening	 of	 the	 vertebral	 upper	 and	 lower	 lamina	 from	 Th8	
to	L1.	The	greatest	changes	occurred	in	the	vertebral	bodies	of	
Th8	 and	 L1,	 where	 codfish	 appearance	 was	 seen.	 Intrathecal	
movements	were	not	demonstrated.	Adjacent	intervertebral	discs	
revealed	 signs	 of	 degenerative	 changes	 -	 reduction	 in	 height	
(except	for	Th12/L1	and	L1/L2),	presence	of	small	gas	bubbles	
(vacuum	symptom)	and	discrete	bulging	of	fibrous	rings.	Slight	
compression	 of	 the	 anterior	 part	 of	 the	 dural	 sack	 was	 seen.	
Visualized	spinal	cord	and	cauda	equina	roots	were	normal.	
Current	 BMD:	 L2-L4	 -	 0.971	 g/cm²,	 T-score:	 -1.91	 SD,	
Z-score:	-1.77	SD.
Figure 1. MRI of the thoraco-lumbar spine. Codfish appearance of Th8 and L1. 
Discrete bulging of fibrous rings.
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Continuation	 of	 the	 treatment	 and	 rehabilitation	 program	
were	advised.	
Discussion
Osteoporosis	is	a	condition	characterized	by	low	bone	mineral	
density	and	disturbed	bone	microarchitecture,	which	in	turn	leads	
to	fractures.	In	postmenopausal	osteoporosis	there	are	certain	risk	
factors	for	fracture,	which	can	be	identified	and	even	quantified.	
On	the	other	hand,	etiopathogenesis	of	PAO	remains	unclear.	So	
far,	it	has	not	been	clearly	explained	why	some	pregnant	women	
suffer	from	severe	loss	of	bone	mass,	whereas	others	do	not.	In	
the	 presented	 patient	 the	 classical	 risk	 factors	 for	 osteoporosis	
and	fracture	were	not	present.	However,	there	are	data	reporting	
they	do	co-exist	in	women	with	PAO	more	often	than	in	healthy	
ones	(for	example	low-energy	fracture	in	family	history)	[1].
The	 fact	 that	 raises	 interest	 in	 this	 particular	 case	 is	 the	
relatively	late	menarche	-	in	Poland	the	average	age	of	menarche	
is	12	years	and	9	months	[2].	One	cannot	exclude	that	deterioration	
of	bone	quality	might	have	occurred	in	the	first	pregnancy,	as	it	
is	usually	reported	in	PAO,	but	was	not	diagnosed	then.	Similar	
situation	 was	 described	 in	 the	 literature	 [3].	 In	 addition,	 in	
women	with	previously	diagnosed	PAO,	fractures	in	subsequent	
pregnancies	might	happen,	although	it	is	not	common	[1].	Patients	
should	be	informed	about	such	risk.	
Parity	 and	 lactation	 –	 contrary	 to	 popular	 opinions	 –	 do	
not	 contribute	 to	 permanent	 deterioration	 of	 BMD.	 The	 fact	
remains	 that	 there	 are	 changes	 in	 the	 calcium	 metabolism	
during	 pregnancy	 –	 the	 fetus	 receives	 an	 amount	 of	 calcium	
representing	only	2-3%	of	its	total	content	in	the	mother’s	body.	
Even	despite	this,	the	mother	adapts	to	the	changing	conditions	
through	increased	intestinal	absorption	and	renal	reabsorption	of	
calcium	and	vitamin	D	synthesis	in	the	kidneys	[4].	Undeniably,	
the	average	loss	of	BMD	during	pregnancy	is	ca.	5%,	however,	
current	 data	 show	 that	 after	weaning	BMD	 returns	 to	 baseline	
within	 6-12	 months	 [5].	 Such	 condition	 corresponds	 with	 the	
concept	of	transient	osteoporosis	of	pregnancy	(TOP)	[6].	
Moreover,	most	 of	 the	 studies	 report	 lack	 of	 difference	 in	
both	 BMD	 and	 incidence	 of	 osteoporosis	 in	 later	 life	 among	
women	who	were	pregnant	at	least	once	and	nulliparas	[7].	The	
former	were	 shown	 to	 have	 3-5%	 higher	BMD	 than	 the	 latter	
[8].	Large	clinical	studies	–	SOF	[9],	MEDOS	[10],	EVOS	[11]	
-	 reported	 the	same	incidence	of	fractures	 in	women	who	gave	
birth	and	nulliparas.
There	 are	 several	 hypotheses	 attempting	 to	 explain	 the	
etiopathogenesis	of	PAO.	The	main	reason	for	low	BMD	is	most	
probably	the	loss	of	the	protective	effects	of	estrogens	on	bone	and	
hyperprolactinemia	accompanying	lactation.	It	is	also	postulated	
that	bone	resorption	in	the	course	of		PAO	may	be	the	result	of	
increased	secretion	of	PTHrP	 from	 the	mammary	gland	during	
lactation	[12].	There	are	isolated	reports	of	calcitonin	deficiency	
adversely	affecting	bone	[5].	Some	authors	have	also	raised	the	
issue	of	pre-pregnancy	osteopenia,	which	is	difficult	to	verify	due	
to	paucity	of	data	on	PAO.	
Women	with	PAO	were	usually	shown	to	have	lower	BMD	
and	T-score	in	the	lumbar	spine	than	in	the	hip	[13].	We	confirmed	
this	observation	(T-score	=	-3.3	SD	vs.	-2.0	SD,	respectively).
In	addition	to	kypho-	and	vertebroplasty	in	the	postpartum	
period	 that	 followed	 vertebral	 fractures	 in	 course	 of	 PAO	 and	
were	 presented	 elsewhere,	 low-energy	 fractures	 of	 acetabulum	
and	femoral	neck	which	required	total	hip	replacement	were	also	
reported	[14].
Importantly,	 there	is	a	question	of	 the	recognition	of	PAO,	
which	is	de	facto	premenopausal	osteoporosis.	WHO	definition	of	
osteoporosis	is	based	on	BMD	and	T-score	by	means	of	DEXA.	
However,	it	applies	to	postmenopausal	osteoporosis	and	therefore	
should	not	be	used	to	diagnose	younger	patients.	In	such	cases	
the	International	Society	for	Clinical	Densitometry	recommends	
to	use	DEXA	Z-score.	A	Z-score	of	-2.0	or	 lower	 is	defined	as	
‘below	the	expected	range	for	age’,	and	a	Z-score	above	-2.0	is	
‘within	the	expected	range	for	age’.	The	diagnosis	of	osteoporosis	
was	undeniable	in	the	case	of	our	patient,	not	only	because	of	the	
densitometric	parameters	but	also	due	to	low-energy	fractures.	
Because	of	the	rarity	of	PAO	and	its	unknown	etiology,	there	
are	 no	 established	 treatment	 protocols	 and	 long-term	 effects	
of	 such	 therapy.	 Women	 usually	 benefit	 from	 treatment	 with	
bisphosphonates	and	calcitonine.	There	were	also	some	reports	
about	 cases	 of	 strontium	 ranelate	 therapy	 [1].	 Some	 authors	
reported	that	in	women	with	PAO	treated	with	bisphosphonates,	
the	 increase	 in	BMD	 is	 relatively	 higher	 than	 in	 patients	with	
postmenopausal	osteoporosis	[15].
In	conclusion,	it	should	be	clearly	stated	that	special	attention	
should	be	given	to	pregnant	women	with	back	pain,	that	can	be	
indicative	of	PAO	–	a	 rare,	but	serious	disease	with	significant	
clinical	implications.	
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